| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.42 | 0.007 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |